Spray-drying process preserves the protective capacity of a breast milk-derived Bifidobacterium lactis strain on acute and chronic colitis in mice

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Burns, Patricia ^a,b   Alard, Jeanne ^a   Hrdy, Jiri ^a,d   Boutillier, Denise ^a   Paéz, Roxana ^c   Reinheimer, Jorge ^b   Pot, Bruno ^a   Vinderola, Gabriel ^b   Grangette, Corinne ^a  

^a UNIV LILLE   (France)

^b UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^c INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA   (Argentina)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ANIMAL; ARGENTINA; BIFIDOBACTERIUM ANIMALIS; BREAST MILK; COLITIS; DESICCATION; DISEASE MODEL; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUSE; PHARMACEUTICS; PHYSIOLOGY; PROCEDURES;

ANIMALS; ARGENTINA; BACTERIOLOGICAL TECHNIQUES; BIFIDOBACTERIUM ANIMALIS; COLITIS; DESICCATION; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICROBIAL VIABILITY; MILK, HUMAN; PROBIOTICS; TECHNOLOGY, PHARMACEUTICAL;

EID: 85013786121     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep43211     Document Type: Article

References (42)

1. Bouma, G., Strober, W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3, 521-533 (2003).
2. Dave, M., Purohit, T., Razonable, R., Loftus, E. V., Jr. Opportunistic infections due to inflammatory bowel disease therapy. Inflammatory bowel diseases 20, 196-212 (2014).
3. Manichanh, C., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211 (2006).
4. Lepage, P., et al. Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 11, 473-480 (2005).
5. Food and Agricultural Organization of the United Nations and World Health Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. World Health Organization [online], http://www. who. int/foodsafety/publications/fs-management/en/probiotics. pdf (2001).
6. Hill, C., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature reviews 11, 506-514 (2014).
7. Ghouri, Y. A., et al. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol 7, 473-487 (2014).
8. Marteau, P., et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 55, 842-847 (2006).
9. Foligne, B., et al. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 13, 236-243 (2007).
10. De Filippo, C., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107, 14691-14696 (2010).
11. Sybesma, W., Kort, R., Lee, Y. K. Locally sourced probiotics, the next opportunity for developing countries? Trends Biotechnol 33, 197-200 (2015).
12. Vinderola, G., et al. Preservation of functionality of Bifidobacterium animalis subsp. lactis INL1 after incorporation of freeze-dried cells into different food matrices. Food Microbiol 30, 274-280 (2012).
13. Zacarias, M. F., Binetti, A., Laco, M., reinheimer, J., Vinderola, G. Preliminary technological and probiotic characterization of bifidobacteria isolated from breast milk for use in dairy products. International Dairy Journal 21, 548-555 (2011).
14. Zacarias, M. F., Reinheimer, J., Forzani, L., Grangette, C., Vinderola, G. Mortality and translocation assay to study the protective capacity of Bifidobacterium lactis INL1 against Salmonella Typhimurium infection in mice. Benef Microbes 5, 427-436 (2014).
15. Muller, J. A., Stanton, C., Sybesma, W., Fitzgerald, G. F., Ross, R. P. Reconstitution conditions for dried probiotic powders represent a critical step in determining cell viability. J Appl Microbiol 108, 1369-1379 (2010).
16. Makinen, K., Berger, B., Bel-Rhlid, R., Ananta, E. Science and technology for the mastership of probiotic applications in food products. J Biotechnol 162, 356-365 (2012).
17. Gardiner, G. E., et al. Comparative survival rates of human-derived probiotic Lactobacillus paracasei and L. salivarius strains during heat treatment and spray drying. Appl Environ Microbiol 66, 2605-2612 (2000).
18. Geier, M. S., Butler, R. N., Giffard, P. M., Howarth, G. S. Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats. Int J Food Microbiol 114, 267-274 (2007).
19. Foligne, B., et al. A key role of dendritic cells in probiotic functionality. PLoS ONE 2, e313 (2007).
20. Foligne, B., et al. Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects. Dig. Dis. Sci. 51, 394-404 (2006).
21. Moss, A. C. The meaning of low-grade inflammation in clinically quiescent inflammatory bowel disease. Current opinion in gastroenterology 30, 365-369 (2014).
22. Sokol, H., et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15, 1183-1189 (2009).
23. Gueimonde, M., Ouwehand, A., Huhtinen, H., Salminen, E., Salminen, S. Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol 13, 3985-3989 (2007).
24. Sokol, H., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences of the United States of America 105, 16731-16736 (2008).
25. Gionchetti, P., et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebocontrolled trial. Gastroenterology. 119, 305-309 (2000).
26. Guslandi, M., Giollo, P., Testoni, P. A. A pilot trial of Saccharomyces boulardii in ulcerative colitis. European journal of gastroenterology & hepatology 15, 697-698 (2003).
27. Tursi, A., et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. The American journal of gastroenterology 105, 2218-2227 (2010).
28. Saez-Lara, M. J., Gomez-Llorente, C., Plaza-Diaz, J., Gil, A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. BioMed research international 2015, 505878 (2015).
29. Martin, R., et al. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol 75, 965-969 (2009).
30. Fernandez, L., et al. The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res 69, 1-10 (2013).
31. Prescott, S. L., et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 160, 4730-4737 (1998).
32. Gueimonde, M., Laitinen, K., Salminen, S., Isolauri, E. Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology 92, 64-66 (2007).
33. Klement, E., Cohen, R. V., Boxman, J., Joseph, A., Reif, S. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. The American journal of clinical nutrition 80, 1342-1352 (2004).
34. Wildt, S., Nordgaard, I., Hansen, U., Brockmann, E., Rumessen, J. A randomized double-blind placebo-controlled trial with Lactobacillus LA-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission un ulcerative colitis. J Crohn's colitis 5, 115-121 (2011).
35. Peighambardoust, S., Golshan, A., Hesari, J. Application of spray drying for preservation of lactic acid starter cultures: A review. Trends in Food Science & Technology 22, 215-224 (2011).
36. Paez, R., et al. Study of the effects of spray-drying on the functionality of probiotic lactobacilli. The Journal of dairy research 66, 155-161 (2013).
37. Simpson, P. J., Stanton, C., Fitzgerald, G. F., Ross, R. P. Intrinsic tolerance of Bifidobacterium species to heat and oxygen and survival following spray drying and storage. J Appl Microbiol 99, 493-501 (2005).
38. Laconelli, C., et al. Drying process strongly affects probiotics viability and functionalities. J Biotechnol 214, 17-26 (2015).
39. Rudensky, A. Y. Regulatory T cells and Foxp3. Immunological reviews 241, 260-268 (2011).
40. IDF26A Dried milk and dried cream, determination of water content. (1993).
41. Wallace, J. L., MacNaughton, W. K., Morris, G. P., Beck, P. L. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 96, 29-36 (1989).
42. Ameho, C. K., et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 41, 487-493 (1997).